Latest news about Dr. Agrawals Eye Hospital
Dr. Agrawals Eye Hospital
5,100.10
+6.10(+0.12%)
Company Performance:
View Company Insights1D+0.12%
1M+6.52%
6M+6.52%
1Y+6.52%
5Y+6.52%
More news about Dr. Agrawals Eye Hospital
30Oct 25
Dr. Agarwal's Eye Hospital Reports Q2 Results, Declares ₹3 Interim Dividend, Approves Amalgamation Scheme
Dr. Agarwal's Eye Hospital has approved Q2 and H1 FY2023-24 financial results. The company declared an interim dividend of ₹3 per equity share, with a record date of November 7, 2023. The Board approved a proposed amalgamation with Dr. Agarwal's Health Care Limited. A preferential issue of 4,32,827 equity shares at ₹5,270 per share to Dr. Agarwal's Health Care Limited was completed on September 26, 2023.
27Aug 25
Dr. Agarwal's Eye Hospital Approves Merger with Parent Company and Preferential Share Allotment
Dr. Agarwal's Eye Hospital Limited (DAEHL) board approves merger with parent company Dr. Agarwal's Health Care Limited (AHCL). AHCL to issue 23 equity shares for every 2 DAEHL shares. Additionally, DAEHL approves preferential allotment of 132,827 shares to AHCL at ₹5,270 per share, increasing AHCL's stake from 71.90% to 72.67%. Merger aims for operational efficiencies, integrated capital allocation, simplified governance, and shareholder value creation. Transaction subject to regulatory approvals.
12Aug 25
Dr. Agarwal's Eye Hospital Reports 23% Surge in Q1 Net Profit
Dr. Agarwal's Eye Hospital announced strong Q1 financial results with net profit rising to ₹17.26 crore, a 22.32% year-over-year increase. Revenue grew to ₹116.92 crore, up from ₹100.02 crore in the previous year. EBITDA for Q1 stood at ₹37.93 crore. The company's performance indicates robust growth in both revenue and profitability, with significant improvements across key financial metrics.
28May 25
Dr Agarwals Eye Hospital Reports Strong Q4 Results, Declares Dividend
Dr Agarwals Eye Hospital announced impressive Q4 results for the fiscal year. Revenue increased by 23.46% to ₹1000.00 million, EBITDA grew by 29.92% to ₹317.00 million, and net profit rose by 25% to ₹160.00 million. The company's EBITDA margin improved to 31.70%. Additionally, a dividend of ₹3.50 per share was declared.
Industry Peers
Apollo Hospitals
Max Healthcare Institute
Fortis Healthcare
Aster DM Healthcare
Narayana Hrudayalaya
Global Health
Krishna Institute of Medical Sciences
Dr. Agarwal's Health Care
Rainbow Childrens Medicare
Park Medi World
8,074.50
(-0.55%)
1,054.15
(+0.44%)
970.10
(-0.06%)
760.00
(+1.79%)
1,838.10
(+1.03%)
1,259.90
(+3.96%)
765.25
(-1.04%)
450.45
(+0.94%)
1,332.20
(+1.22%)
243.43
(-2.07%)
Get More Market Insights with
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
